Sandoz Infringed Amgen's Psoriasis Drug Patents, Court Says
A New Jersey federal judge on Monday found that Sandoz and Zydus Pharmaceuticals infringed several of Amgen's patents for its blockbuster plaque psoriasis medication Otezla, entering judgment in favor of Amgen...To view the full article, register now.
Already a subscriber? Click here to view full article